ArticleInterleukin 36α Serum Level in Egyptian Patients with Systemic Lupus Erythematosus and its relation to Disease Activity
ArticleInterleukin 36α Serum Level in Egyptian Patients with Systemic Lupus Erythematosus and its relation to Disease Activity
ArticleClinical Association of Serum Interleukin-17 and Interleukin-6 in Systemic Lupus Erythematosus Patients
ArticleClinical Association of Serum Interleukin-17 and Interleukin-6 in Systemic Lupus Erythematosus Patients
ArticleSerum interleukin 29 in Rheumatoid Arthritis and Systemic Lupus Erythematosus patients and its association with disease activity.
ArticleSerum interleukin 29 in Rheumatoid Arthritis and Systemic Lupus Erythematosus patients and its association with disease activity.
ArticleCirculating IL 6 and IL 23 Levels in Systemic Lupus Erythematosus Patients and Association with Disease Activity
ArticleCirculating IL 6 and IL 23 Levels in Systemic Lupus Erythematosus Patients and Association with Disease Activity
ArticleInterleukin-22 and Tumor Necrosis Factor Receptor Associated Factor 1 (TRAF1) in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation with Disease Activity
ArticleInterleukin-22 and Tumor Necrosis Factor Receptor Associated Factor 1 (TRAF1) in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation with Disease Activity
ArticleSerum Interleukin-17 Level in Patients with Rheumatoid Arthritis and its Relation to Disease Activity
ArticleSerum Interleukin-17 Level in Patients with Rheumatoid Arthritis and its Relation to Disease Activity